Analysis of The 2024 ESC/EACTS Guidelines For The Management Of Atrial Fibrillation
Recommendations
As issued by the authors
AF-CARE pathway: Comorbidity and risk factor management, Avoiding stroke and thromboembolism, Reducing symptoms through rate and rhythm control, Evaluation and dynamic reassessment
Shared decision making involving patients, families, caregivers and healthcare teams
Healthcare equity: eliminate disparities related to sex, ethnicity, disability and socioeconomic status
ECG confirmation of clinical atrial fibrillation (AF), then risk stratification with CHA₂DS₂-VASc to guide anticoagulation
Direct oral anticoagulants preferred for most patients
Rhythm control first-line for suitable patients
Catheter ablation recommended for persistent symptoms despite medications
Rate control with beta-blockers, digoxin and calcium channel blockers
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →